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multiple disciplines, and ontology-driven mining approaches can generate great value for modeling
disease mechanisms. However, in the case of neurodegenerative diseases such as Alzheimer’s
disease, there is a lack of formal representation of the relevant knowledge domain.
Methods: Alzheimer’s disease ontology (ADO) is constructed in accordance to the ontology
building life cycle. The Protege OWL editor was used as a tool for building ADO in Ontology
Web Language format.
Results: ADO was developed with the purpose of containing information relevant to four main
biological views—preclinical, clinical, etiological, and molecular/cellular mechanisms—and was
enriched by adding synonyms and references. Validation of the lexicalized ontology by means of
named entity recognition-based methods showed a satisfactory performance (F score 5 72%). In
addition to structural and functional evaluation, a clinical expert in the field performed a manual
evaluation and curation of ADO. Through integration of ADO into an information retrieval
environment, we show that the ontology supports semantic search in scientific text. The usefulness
of ADO is authenticated by dedicated use case scenarios.
Conclusions: Development of ADO as an open ADO is a first attempt to organize information
related to Alzheimer’s disease in a formalized, structured manner. We demonstrate that ADO is
able to capture both established and scattered knowledge existing in scientific text.
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Alzheimer’s disease (AD) is a progressive neurodegen-
erative disorder of the brain that leads to irreversible loss
of neurons with age, resulting in severe memory loss andely available to the research community at http://
de/en/business-research-areas/bioinformatics/down
tegrated into SCAIView for information retrieval
essed at www.scaiview.com.
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16/j.jalz.2013.02.009cognitive dysfunction. Currently, AD can neither be
prevented nor cured and is predicted to become a global
threat by 2050 [1]. Hence, exigency of action and promo-
tion of research activities becomes even more important.
The Internet and other knowledge resources are replete
with information on AD generated by the scientific
community. A simple search with the term “Alzheimer’s
disease” using the PubMed search engine produced
72,371 articles on June 21, 2012, and this number is
steadily increasing. However, the gap between data
generated and the knowledge derived from it is apparently
not closing. One of the cardinal reasons accountable for-ND license.
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representing relevant knowledge specific to AD. For
research activities focusing on AD treatment to be
ultimately successful, there is a vital need for knowledge
aggregation from different resources (e.g., literature,
experimental results, and databases). No single system
is currently capable of covering the complete domain of
AD by itself, and manual effort is insufficient to retrieve
and comprehend all relevant information in this domain,
which makes it necessary to develop an interoperable
and standardized semantic framework that enables the sci-
entific community to contribute equally to the representa-
tion of the AD knowledge domain.
Formal ontologies with their potential to engineer
specific knowledge domains can be beneficial to overcome
this hurdle. For instance, gene ontology [2] and SNOMED
(Systematized Nomenclature of Medicine–Clinical Terms)
[3] have facilitated the procedure of annotation and effective
clinical recording of data. Knowledge engineering via
application of ontologies to different knowledge domains
has been used extensively as a basis for information retrieval
and information integration as well [4].
Engineering knowledge using ontologies involves the
specification of concepts and relations that exist in the
domain, as well as their definitions, properties, and con-
strains. Currently, the main online repository of ontol-
ogies, BioPortal (http://bioportal.bioontology.org/),
contains only one generalized disease ontology—namely,
human disease ontology (http://bioportal.bioontology.org/
ontologies/1009; last accessed April 22, 2012) that has
been designed to link distant data sets through disease
concepts. This ontology tries to combine epidemiological
concepts, genetic information, symptoms, and findings
into a disease scenario. However, the broad coverage
and the lack of depth in this ontology restrict its usage
for specific disease domains such as AD. Extensive efforts
have been undertaken to organize published knowledge
related to AD in the form of the AlzSWAN knowledge
base (http://www.alzforum.org/), which is supposed to
be the reference repository for AD-based information
available on the Web. Still, information density or scal-
ability remains a challenge for AlzSWAN.
Motivated by the participation of Fraunhofer Institute
SCAI as a bioinformatics partner in the Neuroallianz
Consortium (a part of the BioPharma initiative of the
German Ministry of Education and Research) and the lack
of an efficient computer readable system to represent the
structure of knowledge in the AD domain, we developed
a first draft of an ontology representing clinical features,
treatment, risk factors, and other aspects of the current
knowledge in the domain of AD. It is noteworthy that, al-
though Alzheimer’s disease ontology (ADO) has been de-
signed in a way to comply with standard upper ontologies,
our attempt was concentrated on keeping the concept defini-
tions close to the expressions in natural language. The hier-
archical structure of the ontology thus can serve as a robustnavigation tree for terminology integration and text-mining
applications.2. Methods
ADO is constructed in accordance with the ontology
building life cycle [5]. To be compliant with the construction
of formal ontologies, we followed the principle criteria of
top-level ontologies applying the basic formal ontology
upper level concepts [6]. The Protege OWL editor (Version
4.2.0) was used as a tool for building ADO in OntologyWeb
Language (OWL) format (http://protege.stanford.edu/).
Scope and domain coverage of ADO were evaluated by
answering three competency questions, which were defined
by two experts in clinical/molecular and pharmaceutical AD
research.
2.1. Knowledge acquisition and conceptualization
A first collection of terms and concepts related to ADwas
generated by scanning various knowledge sources, including
review articles, content of online books, standard knowledge
bases, encyclopedias, glossaries, and informative online
sources and websites. Most of the disease-specific knowl-
edge was acquired by performingWeb-based searches on re-
sources that focus on various aspects of the disease, such as
treatment aspects (http://www. alzheimerstreatment.org/),
research overviews (http://www.alzinfo.org/), neurological
perspectives (http://neurology.health-cares.net/), diagnostic
criteria (http://alzheimers.about.com/), research proceed-
ings (http://www.Omnimedicalsearch.com), and so forth.
Concepts were also extracted from compendiums such as
the Encyclopedia of Alzheimer’s Disease [7] and the Atlas
of Alzheimer’s Disease [8]. Another glossary of terms
representing AD was collected from the Bibliography and
Dictionary of Alzheimer’ Disease [9]. Whenever possible,
any available hierarchical organization (structure) of the
concepts was also extracted along with the concepts
themselves. Corresponding definitions and synonyms were
also taken into consideration as additional annotation of
the concepts.
2.2. Formal representation and concept analysis
Basic formal ontology compliance of ADO as shown in
Fig. 1 ensures its interoperability with existing and future
biomedical ontologies [10]. To be able to generate the
biological views on root subdomains of the ontology,
axiomatic class definitions were added. By this means,
a reasoner can be run to classify automatically other classes
as subclasses of these “views,” which are neither a subclass
of “occurrent” nor of “continuant.”
2.2.1. Reasoner run
ADO was tested with regard to formal consistency
and absence of cycles using the Fast Classification of
Terminologies FaCT11 description logic reasoner [11].
Fig. 1. (A) Alzheimer’s disease ontology (ADO) contextual view classes alongside basic formal ontology (BFO). (B) Example class (Life style) in its BFO
position (top) and in its inherited ADO view position (bottom).
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A text corpus of approximately 54,000 abstracts specific
for AD was used to generate a list of n-grams (n 5 2 . . . 5)
that occur frequently in scientific text related to the disease.
N-grams were ranked according to the frequency of their
occurrence and, if found suitable, were included in the ontol-
ogy either as concepts or synonyms. In search of frequently
recurring noun phrases (NPs) in the same text corpus, an NP
chunking tool (http://opennlp.sourceforge.net/projects.html)
was used. Ranked NPs were evaluated manually and used to
complement the ontology.
2.2.3. Synonym enrichment
Classes were annotated with synonyms, both manually
and in an automated way, making use of mappings to
external ontologies. For this purpose, services provided by
the National Center for Biomedical Ontology were used to
retrieve synonym information [12].2.3. Terminology analysis and concept enrichment
Transformation of the ontology OWL format into
a dictionary file was achieved using a Java program that
extracts the concept names and the corresponding synonyms
from the ontology OWL structure and assigns unique
identifiers to each concept that can be stored in form of
a dictionary. This dictionary was incorporated into
ProMiner, a named entity recognition software program
[13]. In a subsequent step, various class concepts were
used as keywords for search in PubMed to build a corpusthat covers domain information related to topics such as
AD biomarkers, brain regions, diagnostic procedure,
pharmacology, epidemiology, etiology, genetics, pathogene-
sis, stages, symptoms, clinical trials, risk factors, and many
more. From the result list obtained by each concept search,
several abstracts were chosen randomly. After compilation
of these chosen abstracts, a corpus of 500 abstracts was
formed and divided randomly into a training set (250 ab-
stracts), which was used for extracting the terminology man-
ually and building the dictionary, and an annotation set for
the development of the gold standard (250 abstracts). From
the latter, a test set of 200 abstracts was selected. To create
the reference gold standard, suitable annotation guidelines
were developed so that the annotator is guided to keep
the breadth and depth of the ontology in mind and to con-
sider not only the superclass concepts, but also their corre-
sponding subclass concepts as well as their synonyms for
annotation.
Using these annotation guidelines, both training and test
sets were annotated manually by means of the Knowtator
tool (http://knowtator.sourceforge.net/). For enrichment
purposes (optimizing the dictionary), the training set was
analyzed for false-negative entities, which were added to
the ADO terminology after individual expert evaluation.
Moreover, an expert in the field cross-checked the whole
ontology, and additional knowledge was incorporated. The
test set served as the gold standard as well, because the
evaluation process requires performance of comparisons
between the automatically and manually annotated text
from the same set.
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of measuring the boundaries of the knowledge domain
that it captures, precision, recall, and F-score values were
calculated. These values were computed based on the
longest string match found between automatically annotated
terms by ProMiner and the (human) gold standard
annotation for each abstract in the selected corpus. The
following equations were used for the computation of recall,
precision, and F-score values [14].
Precision 5
True positives
True positives1False positives
Recall 5
True positives
True positives1False negatives
F score 5
2!Precision!Recall
Precision1Recall
where true positives are the number of entities that were
found by ProMiner and that matched the annotation in the
gold standard, false positives are the number of entities
that were annotated automatically by ProMiner but could
not be matched to annotations in the (expert annotated)
gold standard, and false negatives are the number of entities
that were not found by ProMiner when compared with the
manual gold standard annotation.
2.4. Visualization of concepts through the text
To visualize the named entities embedded in the textual
body of PubMed abstracts, the transformed Extensible
Markup Language (XML) structure of ADO was integrated
into SCAIView [15]. SCAIView is a visualization interface
for ProMiner annotations and displays named entities by
markup of the text. The key feature of SCAIView is the
ability to perform ontological searches in biomedical text
using concept hierarchies and synonyms associated with
each concept. To adopt ADO in the SCAIView environment,
we extracted the inferred views on the ontology and
transformed the ontology OWL file into XML format
containing the view taxonomy, labels, and synonyms. A
ProMiner annotation run with an ADO-derived dictionary
generated the meta-information (index) used for searching
of ADO terms in SCAIView. Moreover, to reduce the
complexity of the hierarchy for better navigation, improve
the visualization of the concepts, and increase the specificity,
we transferred all the concepts common among general
neurodegenerative diseases to a separate hierarchy called
neurodegenerative diseases (NDD). This utility, along with
the flattened tree structure of ADO, is accessible online at
www.scaiview.com.Fig. 2. Extracted Views on Alzheimer’s disease ontology.3. Results
3.1. ADO structure and contents
ADO covers a wide range of key concepts and aims to
engineer knowledge specific to AD. Modeled heterogeneityin this semantic framework tries to touch all relevant
concepts, but the range varies from very general (main
ontology classes) to more specific concepts (concepts
located at the ontology bottom “leaves”). The main views
(root concepts) in ADO covering aspects of AD knowledge
domain include Clinical, Nonclinical, Etiological, and
Molecular and cellular mechanism. Each of these
superclasses has its own subclasses, as shown in Fig. 2.
Subclasses mentioned under “Clinical thing” cover concepts
that have contributed significantly to our understanding of
the pathology, diagnosis, and possible treatment options.
Concepts defined under each subclass tend to be more
domain specific.
Currently, much of the focus of AD research is de-
voted to preclinical studies that are conducted typically
on animals, and it has the potential to play a vital role
in drug discovery and development processes. Concepts
mapping all aspects of Nonclinical studies (ex vivo, in
silico, in vitro, and in vivo) have also been incorporated
into ADO, hence elaborating the knowledge related to
animal models and bioassays used to understand
more completely the biological processes underlying
Alzheimer’s disease.
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covers all aspects that might be responsible for the initiation
of AD, ranging from genetic factors and environmental
influences to morphological changes with effects that vary
from individual to individual. Clinical appearance of AD
is also marked by anatomic changes as well as cellular and
molecular cascades, which together manifest the neuropath-
ological alterations observed in AD.
Furthermore, in ADO, the Molecular and cellular
mechanism view is designed to cover all entities and
biological mechanisms that find a possible role in AD.
Studying the behavior of neurons and other brain cells
at the cellular and molecular levels during AD can pro-
vide insights into the processes that mark its progression.
The semantic relationships “is a,” “has a,” and “part of”
were used to define relation types between pairs of
concepts.3.2. ADO evaluation3.2.1. Structural aspects
The structural features of the ontology reflecting
topological and logical properties were measured by means
of context-free metrics including depth and breadth (related
to the cardinality of paths in a graph), tangledness (related to
multihierarchical nodes), and fan-outness (related to the
dispersion of nodes). Supplementary Table 1 shows various
parameters that were considered in the structural evaluation
of ADO.
3.2.2. Functional aspects
The functional dimension of the ontology reflects the
main purpose of that ontology by specifying a set of
contextual assumptions about an area of interest. Functional
evaluation measures how widely and precisely ontological
concepts represent the semantic space for the indicated
knowledge domain. The boundary of the knowledge domain
addressed by ADOwas estimated by calculating its fitness to
an existing knowledge repository (i.e., PubMed). Using our
state-of-the-art text-mining environment, which takes ADO
hierarchical structure and corresponding dictionary as input,
we were able to evaluate ADO functionally on the prepared
test set (see Methods) and report an F score of 72%. The
result of this evaluation shows that the ontology in its current
form can capture a wide range of AD concepts in theTable 1
Results of competency questions evaluation using ADO within SCAIView compa
Question no. Total SCAIView hits, n Relevant SCAIV
1 23 documents 20 documents
2 130 documents 14 documents ou
3 12 documents 7 documents
Abbreviation: ADO, Alzheimer’s disease ontology.knowledge domain of AD scattered throughout scientific
publications.
3.2.3. Expert evaluation
The expert panel’s revision of the ontological view
structure is considered to be genuine evaluation for dis-
ease ontologies [16]. Following this revision, our ontol-
ogy was curated manually by a team of clinician experts
in the field (also coauthor in manuscript) who added cer-
tain clinically relevant concepts to ADO, increasing its
pragmatic usability.
Two competency queries defined by the expert clinician
and one from a pharmaceutical expert were selected to
evaluate the semantic performance of ADO and its
capability to return appropriate information:
1. Return references linking amyloid beta to synaptic
dysfunction in the mild stage of AD.
2. Return references that associate the total tau protein to
frontotemporal dementia and AD.
3. Return references containing clinical evidence that
correlate cerebrospinal fluid levels of phosphorylated
tau with cerebrospinal fluid amyloid beta 42 and
cognitive decline.
To evaluate these queries, we compared manually
documents returned by ADO in SCAIView with documents
returned by PubMed advanced search using the same
queries. The results of this evaluation are summarized in
Table 1 and details of query formulations are reported in
Supplementary Table 2.
As shown in Table 1, querying SCAIView with the
support of ADO in comparison with querying PubMed us-
ing comparable query formulations for all competency
queries returns better results in terms of both sensitivity
and specificity. These results indicate that ADO-
supported information retrieval improves the chances for
gaining better coverage with focused results in the same
time compared with naive PubMed-based searches.
Also, the knowledge gain in terms of concept recognition
and enrichment is better when performing ontology-based
semantic searches. To -validate this supposition, we used
the third competency query and executed it in SCAIView
under two conditions: using the MeSH (medical subject
heading) dictionary (without using ADO) and using
ADO in conjunction with NDD terminology. Our reason
is that the same corpus is indexed behind SCAIView sored with nonontological search of PubMed
iew hits, n Total PubMed hits, n
Relevant
PubMed hits, n
1 document 1 document
t of top 20 20 documents 7 documents
0 document 0 document
Fig. 3. (A–C) Entities expressed in the competency questions that are annotated by Alzheimer’s disease ontology (ADO) and further identified to be linked to
other ADO concepts such as the ones associated with amyloid beta (Ab), synaptic dysfunction (A), total tau (t-tau) and frontotemporal dementia (B), and
phosphorylated tau (p-tau) and Ab42 (C). AD, Alzheimer’s disease; MAPK, mitogen-activated protein kinase; LTP, long-term potentiation; CSF, cerebrospinal
fluid.
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Fig. 4. Comorbidity captured in electronic health records using Alzheimer’s disease ontology.
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We then checked the document retrieval under both con-
ditions; it turns out that the ontology-based search using
SCAIView (along with all MeSH concepts included as
a subset) was able to highlight approximately five times
more entities than was possible using the MeSH dictio-
nary alone. With this in mind, we tried to derive infer-
ences about the enrichment of the knowledge space
surrounding the basic answer to the query with the help
of ADO concepts—for example, how entities addressed
in the competency queries are linked to other biological
entities and processes (highlighted in the abstracts using
ADO) in an AD context.
Fig. 3 shows that additional knowledge gained by
means of ontological concept enrichment adds greater
value to the original answer found by ADO. Although
ontology-based context modeling has long been acknowl-
edged to be a key aspect in a wide variety of problem do-
mains, the full power of semantic search using a disease
ontology comes with using a combination of the ontology
with entity recognition, as shown by the strategies
discussed previously.Fig. 5. Number of genes reported in the literature to be commonly involved
in Alzheimer’s disease and four comorbid diseases.3.3. Application scenario: Mining electronic health
records of AD patients for comorbidity analysis
Our motivation for the development of ADO was to
extract automatically domain-specific knowledge related
to AD that can be used to gain further insights into the
disease mechanism. To demonstrate further the utility of
ADO, we aimed at capturing knowledge beyond Medline
abstracts. In an evaluation experiment independent from
Medline, we used ADO to mine 650 AD-related elec-
tronic patient health records to screen systematically for
other diseases or disorders that may exist simultaneously
but independently in patients with AD. In medical, terms
this concept is described as a comorbidity analysis [17].
An example of the annotation of relevant terms in elec-
tronic patient records using the ADO dictionary is shown
in Fig. 4.
After analyzing the results obtained by calculation of
term frequencies, we found that hypertension, diabetesmellitus, and stroke are disorders that are reported to oc-
cur frequently in patients who already have AD. This ob-
servation is in good agreement with the scientific
literature [18]. Furthermore, using our named entity
recognition-driven literature mining machinery, we ex-
tracted a list of the top 300 genes associated with these
three diseases in the literature and compared the list
with that of the top 300 AD genes extracted from the lit-
erature using the same methodology. After curation for
their relevance to the indication area, we found 19 com-
mon genes between AD and diabetes mellitus, 14 between
AD and hypertension, and 46 between AD and stroke, as
shown in Fig. 5.
4. Discussion
In recent years, the realization of the benefits of
ontologies for data management, integration, and processing
in biology—and in the neuroscience domain in particular—
has resulted in a surge of interest in developing disease-
specific, high-resolution ontologies such as the epilepsy
ontology [19]. In addition to other controlled vocabularies
in the field, such as BrainML [20], the epilepsy ontology is
the only formal ontology representing NDDs so far.
However, the coverage of this ontology is limited to the
representation of the current diagnostic scheme proposed
by the International League Against Epilepsy (http://www.
ilae.org/), which includes epileptic syndromes, seizures,
electroencephalogram terminology, and a limited number
of general concepts. Such limitations suggest that there is
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a stronger semantic basis for this indication area with new
ontologies capable of capturing and representing disease-
specific knowledge.
ADO has been designed to provide maximum cover-
age, keeping all aspects of AD in mind. It provides differ-
ent “views” on AD in a structured and formalized manner.
During the course of construction of ADO, special
emphasis was applied to aspects of usability of the ontol-
ogy. ADO has been designed to be useful for and applied
by end users via ontology-driven searching of the litera-
ture. One particular scenario for the application of ADO
is the capturing of AD stage-specific knowledge related
to genes and proteins; cross-sectioning of the AD knowl-
edge space using ADO in combination with human gene/
protein terminologies enables extraction of highly specific
pieces of information from the AD knowledge space.
Such specific and complex information extracted from
scientific text can be used to develop models reflecting
the progression of AD per stage at the molecular level
(data not shown). Moreover, new disease-associated genes
can be identified and may serve as candidates for experi-
mental studies. In addition, the application scenario on
electronic patient health record mining presented earlier
demonstrates what can be done with ADO in the area of
reusing routine clinical data for scientific purposes.
When integrated into our information retrieval system,
ADO leveraged the efficiency of semantic information re-
trieval and knowledge representation by providing the
ability to perform ontological searches in two directions:
in-depth use of concept hierarchies and in-breadth use
of synonyms associated with concepts. In addition,
enrichment of the retrieved knowledge with ADO con-
cepts could contribute to the gain of useful information
linked implicitly to the main query.5. Conclusion
Despite the fast growth of knowledge domains describing
neurological disorders, the number of existing ontologies
representing these domains in a formalized and structured
manner is not proportional to the large volume of generated
knowledge. Development of ADO as an open ADO was
a first attempt in this direction, which is by no means
complete and needs constant enrichment by contributions
from the scientific community and experts in the field of
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1. Systematic review: ADO is constructed in accor-
dance with the ontology-building life cycle and
state-of-the-art ontology evaluation techniques
were used to test and to validate the ontology.
2. Interpretation: ADO provides a first draft version of
a semantic framework that is supposed to support re-
search on Alzheimer´s Disease. ADO can be used to
add meta-information to existing AD data, it pro-
vides the basis for efficient information retrieval
and knowledge representation. It can automatically
extract domain-specific knowledge related to AD,
which can be used to gain further insights into dis-
ease mechanisms.
3. Future directions: ADO is a first attempt to develop
an open, public ontology representing relevant
knowledge on Alzheimer’s disease. We do not
claim that ADO covers the entire knowledge re-
lated to the AD knowledge domain. Thus, like
other ontologies, ADO needs continuous improve-
ment and we encourage members of the scientific
community to apply the ontology in order to further
enhance and improve it.References
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